-
Barcelona confirm Jesus arrival from Arsenal
-
UK chalks up hottest summer on record for second year running
-
EU official says it's not time to 'normalize' Russia at G20 finance talks
-
China's Xi visits Egypt as US sanctions threat looms over Iran links
-
RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®
-
RISE Robotics Awarded $100,000 MassVentures Grant to Accelerate Commercialization of Beltdraulic Technology
-
TrendEadvisor Launches Global Multi-Asset Platform Combining Online Investing with Social Trading
-
Global bond sell-off deepens on inflation concerns
-
India's top court drops criminal cases against protesters
-
Germany's far-right AfD promises 'boom' but economists fear worst
-
Philippine couple married in hip-deep floodwaters
-
Former England captain Stokes signs for Adelaide Strikers
-
Villa sign Senegal winger Mbaye from PSG
-
Pakistan selector and ex-captain Misbah resigns after coach sacked
-
Former Peru minister last-minute contender for UN labour agency helm
-
Shein flattens on Hong Kong debut facing global headwinds
-
Messi legacy will 'live forever', says Beckham
-
Eurozone inflation hits three-year high at 3.3% in August
-
'Literally tasting the smoke': Malaysians suffer as haze worsens
-
Man City chase Fernandez, Arsenal eye Alvarez on deadline day
-
Kyiv's defences, 'hybrid' threat from Moscow headline EU talks
-
El Nino hammering Peru anchovy fishing: industry officials
-
Oil extends gains, stocks mostly down as Trump issues fresh Iran warning
-
Mass Russian barrage kills 12 in Kyiv
-
ThinkMarkets Expands Weekend Trading Offering, Launches Weekend League Competition
-
PineX Capital Launches MetaTrader 5 as Prop Firm Expands Trading Platform Offering
-
Tibet activists accuse China of downplaying floods
-
Women survivors face sanitation woes in Nepal relief camp
-
Afghanistan war victims left 'without justice', UN says
-
Oil extends gains, stocks mixed as Trump issues fresh Iran warning
-
Iran president offers US olive branch before Putin meeting
-
Thai resort readies for US carrier's 5,000 sailors
-
China-Nepal flood toll tops 1,000 as tunnel rescue offers last hope
-
AI startup Manus says resumes independent operations
-
Japan to relax overtime regulation under workaholic PM
-
'Massive' Russian missile, drone attack on Kyiv kills 8
-
Thwarted Niger mutiny exposes junta's Russia dependence
-
Defence tech hub Munich booms as Europe rearms
-
Illegal mining ravages S.Africa's economic hub
-
Nigeria rethinks criminalisation of suicide
-
Nepal's wall of missing offers last hope after Himalayan flood
-
Osaka channels NBA icon Iverson to reach US Open second round
-
US to press G20 on light-touch AI regulation
-
Fast-fashion giant Shein plunges 10% on Hong Kong debut
-
2 die in Grand Canyon flash flood, only 1 person unaccounted for
-
South Korea hire former Spain boss Moreno as interim coach
-
US Army Secretary Driscoll submits resignation: White House
-
China-Taiwan friction clouds Pacific summit
-
Oil extends gains, stocks drop as Trump issues fresh Iran warning
-
Two dead after stabbing in New York's Times Square
PathPresenter Receives FDA 510(k) Clearance for Digital Pathology Clinical Viewer
Regulatory milestone clears product for use in primary diagnosis
MONTVILLE, NJ / ACCESS Newswire / June 24, 2025 / PathPresenter (www.pathpresenter.com), a leading Image Management System and workflow platform for digital pathology, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the PathPresenter Clinical Viewer for the purpose of primary diagnosis. This clearance has been issued for use with the Hamamatsu NanoZoomer S360MD Slide scanner NDPI image formats viewed on the Barco NV MDPC-8127 display device.
The Clinical Viewer is a key part of PathPresenter's vendor-agnostic digital pathology image management system (IMS), a comprehensive platform that includes not just slide viewing, but also workflow management, case tracking, image storage and archiving, integration with laboratory information systems (LIS), multi-user access, collaboration tools, and integrated remote second opinion capability.
"Achieving this important regulatory milestone signals PathPresenter's dedication to providing pathologists, institutions and laboratories with the best digital tools," said Patrick Myles, CEO of PathPresenter. "This FDA clearance continues our momentum to help advance the adoption of digital workflows in pathology. Digital pathology enables the kind of precision medicine that has the potential to revolutionize healthcare, and we're proud to offer our robust, secure, and now FDA-cleared solutions to help practitioners and ultimately patients."
Pathology is the bedrock of clinical decision-making, guiding nearly 70% of healthcare decisions. PathPresenter's powerful platform, designed to facilitate viewing, sharing, and collaborating on whole slide images, has been purpose-built to bridge gaps, integrate previously siloed systems, and offer a robust, secure, tech-forward platform that takes maximum advantage of whole slide imaging and digital workflows to serve the ultimate goal of a clinician's work: to provide the best clinical care.
To learn more about the PathPresenter platform for clinical use, visit https://www.pathpresenter.com/clinical-care/.
About PathPresenter
PathPresenter is an enterprise image management and workflow platform for digital pathology. We are on a mission to democratize access to the world's pathology knowledge by connecting pathologists to the vast expertise of their colleagues globally and providing a practical platform to access and use best-in-class AI models. Founded by dermatopathologist and digital pathology pioneer Dr. Rajendra Singh, PathPresenter's clinical viewer has been granted FDA 510(k) clearance for primary diagnosis when paired with qualified digital scanners and its secure, scalable, vendor-agnostic enterprise pathology workflow software has been adopted by tier one medical institutions for clinical care, education, and research. The company has built a thriving community of tens of thousands of users around the world to easily view and share digital pathology images and knowledge. Learn more at www.pathpresenter.com.
Media Contacts
Neil Humphrey, VP of Marketing
[email protected]
+1 519 498 3402
SOURCE: PathPresenter
View the original press release on ACCESS Newswire
D.Lopez--AT